Premium
Clinical care and other categories posters: lipids and fatty liver
Author(s) -
Coleman, RL,
Gray, A,
Broedl, UC,
Fitchett, D,
George, JT,
Woerle, HJ,
Zinman, B,
Holman, RR
Publication year - 2017
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.33_13304
Subject(s) - medicine , fatty liver , disease
To estimate the degree to which cardiovascular risk reductions demonstrated with empagliflozin administration in the EMPA-REG OUTCOME trial might be explained by changes observed in conventional cardiovascular factors during the study